CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquires Cellero, LLC

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired Cellero, LLC for $37.4 million, a transaction completed in August 2020, structured as all cash.

Cellero, LLC operates in Manufacturing Support — cell therapy, is based in United States. Cellero, LLC was a provider of cellular products for cell therapy developers and manufacturers worldwide, with donor sites in the United States.

The addition of Cellero enhances our unique, comprehensive solutions for the high-growth cell therapy market, strengthening our ability to help accelerate clients' critical programs from basic research and proof-of-concept to regulatory approval and commercialization. The purchase price for Cellero was $37.4 million.

Manufacturing Support segment, cell therapy

The addition of Cellero enhances our unique, comprehensive solutions for the high-growth cell therapy market, strengthening our ability to help accelerate clients' critical programs from basic research and proof-of-concept to regulatory approval and commercialization. The purchase price for Cellero was $37.4 million.Charles River FY2020 10-K, Business Acquisitions note

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.